(Q35278853)

7 August 2017

title

Loracarbef concentrations in middle ear fluid (English)

1 reference

7 August 2017

Kusmiesz H

1

1 reference

7 August 2017

Shelton S

2

1 reference

7 August 2017

Brown O

3

1 reference

7 August 2017

Manning S

4

1 reference

7 August 2017

Nelson JD

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

10

1 reference

7 August 2017

page(s)

2030-2031

1 reference

Pharmacokinetics of LY163892 in infants and children

7 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171986

In vitro susceptibilities of common pediatric pathogens to LY163892.

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171986

Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171986

Concentrations of antimicrobial agents in middle ear fluid, saliva and tears

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2291672

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.10.2030

1 reference

7 August 2017

1 reference

7 August 2017

1 reference